Hancock Jaffe Laboratories, Inc. (HJLI) EPS Estimated At $-0.28; 0 Bullish Analysts Covering Esterline Technologies (ESL) - The Yomi Blog

Hancock Jaffe Laboratories, Inc. (HJLI) EPS Estimated At $-0.28; 0 Bullish Analysts Covering Esterline Technologies (ESL)  The Yomi Blog

Analysts expect Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) to report $-0.28 EPS on February, 6.After having $-0.13 EPS previously, Hancock Jaffe ...



Comments

Post a Comment

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease    Vascular Disease Management First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease; Follows ...
Read more